0001562180-21-000275.txt : 20210108
0001562180-21-000275.hdr.sgml : 20210108
20210108204907
ACCESSION NUMBER: 0001562180-21-000275
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210106
FILED AS OF DATE: 20210108
DATE AS OF CHANGE: 20210108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JONES WILLIAM A JR
CENTRAL INDEX KEY: 0001373097
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 21518889
MAIL ADDRESS:
STREET 1: NITROMED, INC.
STREET 2: 125 SPRING STREET
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-01-06
false
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001373097
JONES WILLIAM A JR
C/O BIOHAVEN PHARMACEUTICALS
215 CHURCH STREET
NEW HAVEN
CT
06510
false
true
false
false
CCO-Migraine & Common Disease
Common Shares
2021-01-06
4
M
false
5000.00
0.00
A
9251.00
D
Common Shares
2021-01-06
4
F
false
2124.00
83.38
D
7127.00
D
Employee Stock Option (right to buy)
83.38
2021-01-06
4
A
false
40000.00
0.00
A
2031-01-06
Common Shares
40000.00
40000.00
D
Restricted Share Unit Award
2021-01-06
4
A
false
20000.00
0.00
A
Common Shares
20000.00
20000.00
D
Restricted Share Unit Award
2021-01-06
4
M
false
5000.00
0.00
D
Common Shares
5000.00
15000.00
D
This balance includes 741 shares that were acquired through the Biohaven Employee Share Purchase Plan on November 30, 2020.
No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
The shares underlying this option vest in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continuous service with the Issuer at each vesting date.
Each restricted share unit represents the contingent right to receive one common share of the Issuer.
The reporting person was granted 20,000 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date.
Not applicable.
/s/ Jim Engelhart, Attorney-in-Fact
2021-01-08